Back to BlackRock, Inc. BlackRock, Inc.

COGTCOGT
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in Cogent Biosciences, Inc.

BlackRock, Inc. holds 17.4M shares of COGT (Cogent Biosciences, Inc.), worth $671.5M as of 2026-Q2. The position was increased (+8.2% shares). COGT represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$671.5M

Current Shares

17.4M

Total Value Change

+$606.5M

Total Shares Change

+9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
17.4M
+8.2%
$671.5M0.0%$38.70
34
2026-Q1
Increased
16M
+23.7%
$617.6M0.0%$37.24
38
2025-Q4
Increased
13M
+25.1%
$460.9M0.0%$37.12
38
2025-Q3
Increased
10.4M
+20.2%
$148.9M0.0%$14.13
36
2025-Q2
Increased
8.6M
+5.5%
$61.9M0.0%$7.10
31
2025-Q1
Decreased
8.2M
-2.0%
$49M0.0%$6.48
0
2024-Q4
New
8.3M
-
$65M0.0%$7.71
41

Other major holders of COGT: FMR LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used